Clinical trials
Myelodysplastic Syndromes trials in Finland
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
12 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2004 | 1 |
| 2008 | 1 |
| 2013 | 1 |
| 2017 | 1 |
| 2019 | 1 |
| 2020 | 3 |
| 2021 | 1 |
| 2022 | 1 |
| 2025 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 5 |
| Active, not recruiting | 4 |
| Terminated | 3 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Novartis Pharmaceuticals | 2 |
| medac GmbH | 2 |
| Celgene | 1 |
| Eli Lilly and Company | 1 |
| European Organisation for Research and Treatment of Cancer - EORTC | 1 |
| Faron Pharmaceuticals Ltd | 1 |
| Gilead Sciences | 1 |
| Incyte Corporation | 1 |
| Servier Bio-Innovation LLC | 1 |
| Universitätsklinikum Hamburg-Eppendorf | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Myelodysplastic Syndromes | 12 |
| Leukemia, Myeloid, Acute | 7 |
| Leukemia, Myelomonocytic, Chronic | 5 |
| Leukemia | 3 |
| Recurrence | 3 |
| Myeloproliferative Disorders | 2 |
| Precursor Cell Lymphoblastic Leukemia-Lymphoma | 2 |
| Blast Crisis | 1 |
| Bone Marrow Diseases | 1 |
| Burkitt Lymphoma | 1 |
Trials
Showing 1 to 12 of 12. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.